Fuzhen Wang

Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients

Jun‐liang Fu, Ying-ying Gao, J. Luan, 2022, Frontiers in Immunology.

Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in China

Linghua Li, W. Cai, Xie-jie Chen, 2018, Hepatology International.

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy

Jun‐liang Fu, Jinwen Song, Shuang Zhou, 2022, Frontiers in Microbiology.

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022

Z. Yin, Z. An, H. Zheng, 2022, China CDC weekly.

Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021

Wenzhou Yu, Z. Yin, Hui-hui Zheng, 2022, China CDC weekly.